Does HPV Vaccination Lower Cancer Risk in Males? - Scorecard - MDSpire

Does HPV Vaccination Lower Cancer Risk in Males?

  • By

  • Kerri Miller

  • April 17, 2026

  • 3 min

Share

Clinical Scorecard: Does HPV Vaccination Lower Cancer Risk in Males?

At a Glance

CategoryDetail
ConditionHPV-related cancers in males
Key Mechanisms9-valent HPV vaccine reduces cancer incidence
Target PopulationMales aged 9 to 26 years
Care SettingHealth care centers in the US

Key Highlights

  • Lower incidence of HPV-related cancers in vaccinated males compared to unvaccinated peers
  • Hazard ratio of 0.54 indicates a 46% lower risk of HPV-related cancer
  • Study included over 615,000 vaccinated and 2.3 million unvaccinated males
  • Findings support expanding sex-neutral HPV vaccination programs
  • Results primarily driven by head and neck cancer diagnoses

Guideline-Based Recommendations

Diagnosis

  • Cancer diagnoses based on administrative coding; caution due to potential misclassification

Management

  • Encourage HPV vaccination in males aged 9 to 26 years

Monitoring & Follow-up

  • Monitor cancer incidence and vaccination rates in targeted populations

Risks

  • Limitations include unaccounted risk factors and potential misclassification of vaccination status

Patient & Prescribing Data

Males aged 9 to 26 years

9-valent HPV vaccine is effective in reducing cancer risk

Clinical Best Practices

  • Administer HPV vaccines to both males and females
  • Promote awareness of HPV vaccination benefits in young males
  • Integrate HPV vaccination into routine adolescent health care

References

Original Source(s)

Related Content